ENGITIX

engitix-logo

Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered products for application in regenerative medicine and drug-target research. Engitix’ core expertise is treatment and research of liver disease using its proprietary technologies for human extra-cellular matrix (ECM) scaffolds and 3D spheroids for bioartificial liver devices. The scaffold technology is applicable to other organs and disease aetiologies including pancreatic and intestine scaffold products.

#SimilarOrganizations #People #Financial #Website #More

ENGITIX

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2016-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.engitix.com

Total Employee:
11+

Status:
Active

Contact:
+44 (0)204 530 7654

Total Funding:
60.37 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

menten-ai-logo

Menten AI

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.


Current Advisors List

gianluca-rossetti_image

Gianluca Rossetti Board of Director @ Engitix
Board_member
2022-01-19

michael-edward-platt_image

Michael Edward Platt Board of Director @ Engitix
Board_member
2022-01-19

Current Employees Featured

giuseppe-mazza_image

Giuseppe Mazza
Giuseppe Mazza Chief Executive Officer & Co-Founder @ Engitix
Chief Executive Officer & Co-Founder
2016-07-01

david-dally_image

David Dally
David Dally Chief Financial Officer @ Engitix
Chief Financial Officer
2018-11-01

stephen-brindle_image

Stephen Brindle
Stephen Brindle Chief Operating Officer @ Engitix
Chief Operating Officer

Founder


giuseppe-mazza_image

Giuseppe Mazza

Investors List

dompe_image

DOMPE

DOMPE investment in Series A - Engitix

netherton-investments_image

Netherton Investments

Netherton Investments investment in Series A - Engitix

Official Site Inspections

http://www.engitix.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K

  • Host name: 153.131.153.160.host.secureserver.net
  • IP address: 160.153.131.153
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Engitix"

Engitix – Reshaping Drug Discovery for Fibrosis and …

Engitix appoints two additional international biotech industry leaders as Scientific Advisors 25 June 2024; Engitix Announces Appointment of Matthew Edwards Ph.D., as SVP Discovery and Emma Huang Ph.D., as VP Data Sciences 21 …See details»

About Us - Engitix

Engitix has a 13,000 square feet facility of purpose-designed office and laboratory space that houses the latest state-of-the-art research instruments and tools. Located at the Westworks building in the prestigious new life science cluster …See details»

Leadership - Engitix

Engitix was established to build on and commercialise Giuseppe’s pioneering research which resulted in a proprietary human extracellular matrix ECM drug discovery platform. His …See details»

Engitix - Crunchbase Company Profile & Funding

Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered products for application in regenerative medicine and drug-target research. Engitix’ …See details»

Engitix Therapeutics - LinkedIn

Engitix Therapeutics | 5,768 followers on LinkedIn. Rethinking drug discovery for fibrosis and cancer | To create a healthier future for patients with life-threatening diseases, we are using our ...See details»

Engitix - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Engitix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Chief Executive Officer & Co-Founder …See details»

Engitix Therapeutics Company Profile 2024: Valuation, …

Engitix Therapeutics was founded in 2016. Where is Engitix Therapeutics headquartered? Engitix Therapeutics is headquartered in London, United Kingdom. What is the size of Engitix Therapeutics? Engitix Therapeutics has …See details»

Member profile: Engitix Therapeutics | BIA - BioIndustry

The Engitix platform is highly translational and allows a deep understanding of the disease biology to guide the discovery process. Engitix has now established a portfolio of therapeutic …See details»

Engitix Therapeutics to Relocate Headquarters to White City Place

Sep 2, 2020 Engitix Therapeutics have announced that they will be the latest life science company to move their headquarters to White City Place, with plans to move their laboratory …See details»

Engitix - Overview, News & Similar companies | ZoomInfo.com

Engitix Announces Appointment of Sonia Quaratino, M.D., Ph.D., as Independent Non-executive Director LONDON, May 09, 2023 (GLOBE NEWSWIRE) -- Engitix Ltd (‘Engitix’), a …See details»

Engitix Company Profile - Office Locations, Competitors ... - Craft

Engitix has 5 employees across 3 locations and $6.41 m in total funding,. See insights on Engitix including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»

Media Centre - Engitix

Jun 25, 2024 Engitix Celebrates Move to Expanded Purpose-designed Facilities in White City, West London 5th October 2022. London, UK – 5 October 2022 – Engitix Ltd (‘Engitix’), a …See details»

Takeda bets on Engitix’s ECM drug discovery platform for liver …

Sep 17, 2020 Mazza notes Engitix will use the upfront payment to “expand our team and to advance our internal programs”. The company has three products in the discovery phase of its …See details»

Engitix Signs Collaboration and Licensing Agreement with Takeda …

Aug 25, 2020 Engitix Ltd Giuseppe Mazza, PhD E: [email protected] Instinctif Partners (media enquiries) Agnes Stephens / Katie Duffell T: +44 (0)20 7457 2013 E: …See details»

Engitix Announces Expanded Collaboration and Licensing …

Apr 12, 2022 Collaboration combines Engitix’s unique human extracellular matrix (ECM) platform with Takeda’s expertise in gastroenterology research and development (R&D) and …See details»

Technology - Engitix

Engitix aims to identify novel and more relevant therapeutic targets by deciphering disease-associated changes to the composition of this acellular environment. We can then investigate …See details»

Engitix Therapeutics: beyond the cells - Nature

Engitix has pioneered a platform to decipher and model the complexity of the ECM. For a particular disease, using samples from its own human tissue biobank and proprietary tissue …See details»

Engitix Announces Expanded Collaboration and Licensing …

Apr 12, 2022 LONDON--(BUSINESS WIRE)--#IBD--Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its …See details»

Our Platform – Engitix

Engitix’s platform is underpinned by an extensive bioarchive, one of the world’s largest ECM databases, the Engitomix proprietary bioinformatics platform, and best-in-class, human in vitro …See details»

Careers – Life at Engitix – Engitix

At Engitix, our goal is to stand by you through life’s milestones. That’s why our benefits are crafted to ensure your well-being and happiness at every turn. Access to world-class scientific …See details»

linkstock.net © 2022. All rights reserved